Adding HMB to EPA/DHA supplementation for 10 weeks increases postabsorptive net protein breakdown in COPD patients
In a randomized double-blind placebo-controlled trial, 46 patients with COPD received daily EPA/DHA, EPA/DHA plus HMB, or placebo for 10 weeks. The HMB plus EPA/DHA group showed a significant increase in postabsorptive net protein breakdown (p=0.028), while EPA/DHA alone did not, suggesting enhanced protein turnover cycling associated with lean soft tissue gain.
Evidence Score
Study Evidence
Study 1. Functional and metabolic effects of omega-3 polyunsaturated fatty acid supplementation and the role of β-hydroxy-β-methylbutyrate addition in chronic obstructive pulmonary disease: A randomized clinical trial.
observationalEngelen MPKJ, Simbo SY, Ruebush LE, Thaden JJ, Ten Have GAM, Harrykissoon RI, Zachria AJ, Calder PC, Pereira SL, Deutz NEP ยท Clinical nutrition (Edinburgh, Scotland) (2024)
Result:
Mechanism Graph
Limitations
- โ Small sample size (n=46) may limit generalizability
- โ Whether HMB alone or synergistic with EPA/DHA causes fat loss remains unclear
Frequently Asked Questions
What is the primary finding of this study?โผ
Adding HMB to EPA/DHA supplementation for 10 weeks increases net protein breakdown in COPD patients, indicating enhanced protein turnover, while EPA/DHA alone does not.
How does HMB plus EPA/DHA affect body composition?โผ
Both EPA/DHA and HMB plus EPA/DHA increased lean soft tissue, but only HMB plus EPA/DHA reduced whole body and extremity fat mass.
What is the recommended dose of EPA/DHA and HMB?โผ
The study used 2.0 g of EPA/DHA and 3.0 g of Ca-HMB daily for 10 weeks.
Are there any anti-inflammatory effects observed?โผ
Yes, the HMB plus EPA/DHA group showed reductions in several proinflammatory cytokines including IL-2, IL-6, IL-17, IL-12P40, and TNF-ฮฒ.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Engelen MPKJ, Simbo SY, Ruebush LE, Thaden JJ, Ten Have GAM, Harrykissoon RI, Zachria AJ, Calder PC, Pereira SL, Deutz NEP. "Functional and metabolic effects of omega-3 polyunsaturated fatty acid supplementation and the role of β-hydroxy-β-methylbutyrate addition in chronic obstructive pulmonary disease: A randomized clinical trial.." Clinical nutrition (Edinburgh, Scotland), 2024. PMID: 39181037 DOI: 10.1016/j.clnu.2024.08.004